|
|
Volumn 44, Issue 11, 2009, Pages 984-992
|
|
Gluten content of the top 200 medications of 2008: A follow-up to the impact of celiac sprue on patients' medication choices
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABACAVIR PLUS LAMIVUDINE;
ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE;
ADALIMUMAB;
ADAPALENE;
ADRENALIN;
ALENDRONIC ACID;
ALENDRONIC ACID PLUS COLECALCIFEROL;
ALFUZOSIN;
ALLEGRA D;
ALPHAGAN P;
AMFEBUTAMONE;
AMPHETAMINE;
ANASTROZOLE;
APRI;
ARIPIPRAZOLE;
ATAZANAVIR;
ATOMOXETINE;
ATORVASTATIN;
AVIANE;
AZELASTINE;
BECLOMETASONE DIPROPIONATE;
BENICAR HCT;
BENZACLIN;
BETA1A INTERFERON;
BICALUTAMIDE;
BIMATOPROST;
BRIMONIDINE;
BUDEPRION SR;
BUDEPRION XL;
BUDESONIDE;
BUDESONIDE PLUS FORMOTEROL;
BUPRENORPHINE PLUS NALOXONE;
C PHEN DM;
CANDESARTAN HEXETIL;
CAPECITABINE;
CELECOXIB;
CETIRIZINE;
CINACALCET;
CIPRODEX OTIC;
CLONIDINE;
CLOPIDOGREL;
COLESEVELAM;
CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;
COREG CR;
CRYSELLE;
CYCLOSPORIN A;
DARIFENACIN;
DEPAKOTE ER;
DESLORATADINE;
DEXAMETHASONE PLUS TOBRAMYCIN;
DEXMETHYLPHENIDATE;
DIGITEK;
DIGOXIN;
DONEPEZIL;
DORZOLAMIDE PLUS TIMOLOL;
DOXYCYCLINE;
DROSPIRENONE PLUS ETHINYLESTRADIOL;
DULOXETINE;
DUTASTERIDE;
EFAVIRENZ;
EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
ELETRIPTAN;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
ENBREL SURECLICK;
ENDOCET;
ENOXAPARIN;
ERLOTINIB;
ESCITALOPRAM;
ESOMEPRAZOLE;
ESTRADIOL;
ESZOPICLONE;
ETANERCEPT;
ETHEDENT;
ETHINYLESTRADIOL PLUS ETONOGESTREL;
ETHINYLESTRADIOL PLUS NORELGESTROMIN;
ETIRACETAM;
EXENDIN 4;
EZETIMIBE;
EZETIMIBE PLUS SIMVASTATIN;
FENOFIBRATE;
FENTANYL;
FENTANYL CITRATE;
FEXOFENADINE;
FINASTERIDE;
FISH OIL;
FLOVENT HFA;
FLUTICASONE FUROATE;
FLUTICASONE PROPIONATE PLUS SALMETEROL;
GATIFLOXACIN;
GEODON ORAL;
GLATIRAMER;
GLIPIZIDE XL;
GLUTEN;
HALFLYTELY BOWEL PREP;
HUMALOG MIX 75 35;
HUMINA PEN;
HUMULIN 70 30;
HYDROCHLOROTHIAZIDE PLUS IRBESARTAN;
HYDROCHLOROTHIAZIDE PLUS LOSARTAN;
HYDROCHLOROTHIAZIDE PLUS VALSARTAN;
IBANDRONIC ACID;
IMATINIB;
IMIQUIMOD;
IMITREX ORAL;
INFLUENZA VACCINE;
INSULIN DETEMIR;
INSULIN GLARGINE;
INSULIN LISPRO;
IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE;
IRBESARTAN;
ISOPHANE INSULIN;
JANTOVEN;
JUNEL FE;
KARIVA;
KLOR CON;
LAMIVUDINE PLUS ZIDOVUDINE;
LAMOTRIGINE;
LANSOPRAZOLE;
LANTUS SOLOSTAR;
LATANOPROST;
LENALIDOMIDE;
LETROZOLE;
LEVALBUTEROL;
LEVOCETIRIZINE;
LEVOFLOXACIN;
LEVORA;
LEVOTHYROXINE SODIUM;
LIDOCAINE;
LINEZOLID;
LIOTHYRONINE SODIUM;
LISDEXAMFETAMINE;
LOESTRIN 24 FE;
LOPINAVIR PLUS RITONAVIR;
LOSARTAN POTASSIUM;
LOW OGESTREL;
LUBIPROSTONE;
MAXALT MLT;
MEMANTINE;
MESALAZINE;
METAXALONE;
METFORMIN PLUS PIOGLITAZONE;
METFORMIN PLUS ROSIGLITAZONE;
METFORMIN PLUS SITAGLIPTIN;
METHYLPHENIDATE;
METOPROLOL SUCCINATE;
MICARDIS HCT;
MINOCYCLINE;
MODAFINIL;
MOMETASONE FUROATE;
MONTELUKAST;
MORPHINE SULFATE;
MOXIFLOXACIN;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NASACORT AQ;
NECON 135;
NICOTINIC ACID;
NISOLDIPINE;
NOVOLIN 7030;
OCELLA;
OLANZAPINE;
OLMESARTAN;
OLOPATADINE;
OPANA ER;
ORTHO TRICYCLEN LO;
OSELTAMIVIR;
OXCARBAZEPINE;
OXYCODONE;
PALIPERIDONE;
PANTOPRAZOLE;
PARATHYROID HORMONE[1-34];
PAROXETINE;
PATADAY;
PEGINTERFERON ALPHA2A;
PHENYTOIN;
PIOGLITAZONE;
POLYMAGMA PLAIN;
PRAMIPEXOLE;
PREGABALIN;
PREMARIN TABS;
PREMARIN VAGINAL;
PRIMACARE ONE;
PROAIR HFA;
PROGESTERONE;
PROVENTIL HFA;
PSEUDOMONIC ACID;
QUETIAPINE;
RABEPRAZOLE;
RALOXIFENE;
RALTEGRAVIR;
RAMIPRIL;
RECOMBINANT ERYTHROPOIETIN;
RHINOCORT QUA;
RISEDRONIC ACID;
RISPERIDONE;
RITONAVIR;
RIZATRIPTAN;
ROPINIROLE;
ROSIGLITAZONE;
ROSUVASTATIN;
SEVELAMER;
SILDENAFIL;
SITAGLIPTIN;
SOLIFENACIN;
SOTRET;
SPRINTEC;
TACLONEX;
TACROLIMUS;
TADALAFIL;
TAMSULOSIN;
TELMISARTAN;
TEMOZOLOMIDE;
TENOFOVIR DISOPROXIL;
TESTOSTERONE;
THALIDOMIDE;
THYORID ARMOUR;
TIOTROPIUM BROMIDE;
TOLTERODINE;
TOPIRAMATE;
TRAVATAN Z;
TRAVOPROST;
TRILYTE;
TRINESSA;
TRISPRINTEC;
TUSSIONEX;
ULTRAM ER;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VALACICLOVIR;
VALGANCICLOVIR;
VALPROATE SEMISODIUM;
VALSARTAN;
VARDENAFIL;
VARENICLINE;
VENLAFAXINE;
VENTOLIN HFA;
WARFARIN;
XOPENEX HFA;
YASMIN 28;
ZOLMITRIPTAN;
ZOLPIDEM TARTRATE;
ZOVIRAX TOPICAL;
AVOIDANCE BEHAVIOR;
CELIAC DISEASE;
CLINICAL EVALUATION;
DIET RESTRICTION;
DRUG FORMULATION;
DRUG INDUSTRY;
DRUG MANUFACTURE;
FOLLOW UP;
HUMAN;
IMMUNE RESPONSE;
INGESTION;
MEDICINE;
PATIENT SELECTION;
PHYSICIAN;
REVIEW;
SMALL INTESTINE;
|
|
EID: 75449088485
PISSN: 00185787
EISSN: None
Source Type: Journal
DOI: 10.1310/hpj4411-984 Document Type: Review |
|
Times cited : (6)
|
|
References (5)
|
